Searched for
SANDOZ
Europe’s last penicillin plant faces a bitter fight against China’s cheaper drugsThe Sandoz penicillin plant in Kundl, Austria, is under threat from cheaper Chinese antibiotic production. European healthcare programs ben...- Zydus moves closer to US market for Keytruda biosimilar as FDA accepts applicationZydus Lifesciences has received acceptance for its application regarding the biosimilar of Keytruda, which is a major cancer drug. The USFD...
- ChrysCapital to take minority stake in Linux laboratoriesLinux Laboratories has secured $70 million in equity funding from ChrysCapital and Tata Capital Healthcare Fund III. This investment involv...
- Tata Capital Healthcare Fund to exit Linux Laboratories as ChrysCapital buys 20-25% stakePrivate equity firm ChrysCapital is set to acquire a significant stake in Linux Laboratories. This deal will see existing investor Tata Cap...
- Sandoz bets big on biosimilars, aims to double group sales by 2035Sandoz plans to more than double annual net sales by 2035, with biosimilars leading growth. The company will expand its biosimilar portfoli...
- Global Market: European shares slip as oil surge fuels inflation fears; Novartis plungesEuropean shares slipped as surging oil prices raised inflation concerns amid escalating Middle East tensions and threats to Gulf energy inf...
- Novartis India to pursue therapy-aligned acquisitions; eyes expansion in Tier 2 and Tier 3 marketsNovartis India plans acquisitions and deeper market penetration for future growth. The company will focus on five key therapy areas for exp...
- Biocon arm gets Japan nod for cancer drug pegfilgrastim biosimilarIn a significant advancement, Biocon Biologics has gained marketing approval for its pegfilgrastim biosimilar in Japan. This vital cancer s...
- Global Market: European shares climb as earnings, US-Iran diplomacy lift sentimentEuropean stocks advanced on Wednesday, driven by U.S.-Iran diplomatic talks. Mining companies led the rally as geopolitical concerns eased ...
- Generic drugmaker Sandoz to engage with US after Trump tariff threatUS President Donald Trump threatened steep tariffs on generic drugmakers. He stated medicines must be manufactured locally or face signific...
- Strides Pharma to acquire Sandoz branded generics portfolio to expand Africa businessStrides Pharma Science is preparing to enhance its presence in Sub-Saharan Africa by acquiring branded generic products from Sandoz AG, wit...
- Lupin ties up with Sandoz to commercialise biosimilar productLupin has partnered with Sandoz Group AG to commercialize its biosimilar ranibizumab across multiple regions, with Sandoz handling commerci...
- Novartis to spin off generics biz sandozThe company started a strategic review of Sandoz last October - examining a range of options, including retaining the business, spinning it...
- Aurobindo Pharma aims to become debt free in 3 years sans Sandoz dealIn September last year, the USD three billion drug maker said its US subsidiary entered into an agreement to acquire commercial operations ...
- Biocon teams up with Swiss drugmaker Sandoz for next gen biosimilarUnder the terms of the agreement, both companies will share responsibility for end to end development, manufacturing and global regulatory ...
- Novartis gets USFDA warning letter for two plants in IndiaSandoz, the generic drug arm of Swiss drug major Novartis, has received a warning letter from the US health regulator for violations of cur...
- Sandoz gets US FDA warning letter for Turbhe, Kalwe sitesThe observations in the warning letter dated October 22 are related to deficiencies in current good manufacturing practice (cGMP) for finis...
- Sandoz gets warning letter for Turbhe, Kalwe siteSandoz, the generic drug arm of Swiss giant Novartis, has received a warning letter from the US FDA on October 22 for its two Indian sites ...
- Cipla gains as partner Sandoz gets USFDA approval for generic drugCipla surged over 4% in trade after its partner Sandoz received a USFDA nod to launch a generic version of Pulmicort respules.
- Sandoz Inc recalls India-made anti-allergic tablets in USDrug firm Sandoz Inc is recalling India-made 1,023,430 units of anti-allergic Cetirizine HCl chewable tablets in the US due to impurity con...
Load More
